
Back in 2012 the FDA did approve another drug from Genzyme, who is owned by Sanofi for the treatment of multiple-sclerosis and the current drug they are seeing approval for has been approved in Europe, Canada and Australia. The Genzyme division of Sanofi produced the drug, Aubagio, which is a pill.…